Poietis - Model NGB-C -Bioprinter for Clinical Applications

NGB-C Bioprinter enables the manufacturing of human living tissues in a closed system, under completely aseptic conditions, within an isolator. It relies on Poietis Next-Generation Bioprinting platform and integrates technologies that ensure the repeatability and complete traceability of manufacturing operations.

The commonality between NGB-C and NGB-R Bioprinters will facilitate the transposition of preclinical R&D results to the clinical phases and will accelerate the development and the access to innovative therapies for patients.